文献速递胸部CT

COPDGene研究:10年肺气肿进展的定量CT评估

Quantitative CT Evaluation of Emphysema Progression over 10 Years in the COPDGene Study.
PubMed 文献 · Radiology · 2023-04-11

COPDGene前瞻性队列纳入8431名吸烟者,在基线和5年、10年随访时进行定量CT测量,评估肺气肿进展。结果显示,基线有肺气肿且继续吸烟者调整后肺密度年下降最大(前5年1.4 g/L,后5年0.9 g/L)。校正CT噪声、视野和扫描仪型号后,模型拟合显著改善(P < .001)。

要点

  • 基线有肺气肿且继续吸烟者肺气肿进展最快。
  • 定量CT随访需校正CT技术参数以提高准确性。
  • 调整后肺密度年下降幅度前5年大于后5年。
英文原文(摘要)· 点击展开

Background Long-term studies of chronic obstructive pulmonary disease (COPD) can evaluate emphysema progression. Adjustment for differences in equipment and scanning protocols of individual CT examinations have not been studied extensively. Purpose To evaluate emphysema progression in current and former smokers in the COPDGene cohort over three imaging points obtained at 5-year intervals accounting for individual CT parameters. Materials and Methods Current and former cigarette smokers enrolled between 2008 and 2011 from the COPDGene study were prospectively followed for 10 years between 2008 and 2020. Extent of emphysema as adjusted lung density (ALD) from quantitative CT was measured at baseline and at 5- and 10-year follow-up. Linear mixed models adjusted for CT technical characteristics were constructed to evaluate emphysema progression. Mean annual changes in ALD over consecutive 5-year study periods were estimated by smoking status and baseline emphysema. Results Of 8431 participants at baseline (mean age, 60 years ± 9 [SD]; 3905 female participants), 4913 were at 5-year follow-up and 1544 participants were at 10-year follow-up. There were 4134 (49%) participants who were current smokers, and 4449 (53%) participants had more than trace emphysema at baseline. Current smokers with more than trace emphysema showed the largest decline in ALD, with mean annual decreases of 1.4 g/L (95% CI: 1.2, 1.5) in the first 5 years and 0.9 g/L (95% CI: 0.7, 1.2) in the second 5 years. Accounting for CT noise, field of view, and scanner model improved model fit for estimation of emphysema progression (P < .001 by likelihood ratio test). Conclusion Evaluation at CT of emphysema progression in the COPDGene study showed that, during the span of 10 years, participants with pre-existing emphysema who continued smoking had the largest decline in ALD. Adjusting for CT equipment and protocol factors improved these longitudinal estimates. Clinical trial registration no. NCT00608764 © RSNA, 2023 Supplemental material is available for this article. See the editorial by Parraga and Kirby in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Baraghoshi, Strand, Humphries, et al. Quantitative CT Evaluation of Emphysema Progression over 10 Years in the COPDGene Study. Radiology. 2023. PMID: 37039685. doi:10.1148/radiol.222786

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。